Trial Profile
Clinical Trial of bilateral bevacizumab administration in patient with retinopathy of prematurity
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 12 Mar 2018
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Retinopathy of prematurity
- Focus Therapeutic Use
- 07 Mar 2018 Planned number of patients changed from 40 to 80.
- 06 Jun 2016 New trial record